NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Tuesday reported a loss of $49.4 million in its second quarter.
On a per-share basis, the New York-based company said it had a loss of 55 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.
The biopharmaceutical company posted revenue of $72.8 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $81.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
